Cover Image

PROGRESSIVE CORONARY ARTERY DISEASE, ELEVATED LP (A) REQUIRING LIPID APHERESIS

Therapeutic Area: ASCVD /CVD Risk Reduction Case Presentation: This is a 55-year-old female with a medical history of familial hypercholesterolemia, elevated lipoprotein (a) (Lp (a)), diabetes mellitus, myocardial infarction 2020, coronary artery disease with multiple percutaneous coronary intervent...

Full description

Saved in:

Bibliographic Details
Main Author:	Susan Alideeb, MD (Author)
Format:	Book
Published:	Elsevier, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
by: Sonali Pechlivanis, et al.
Published: (2020)

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
by: Muhammet Bulut, et al.
Published: (2020)

Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia
by: Claudia Stefanutti, et al.
Published: (2016)

Apheresis in Neurological Disorders
Published: (2020)

Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
by: Julia Lischka, et al.
Published: (2022)

Role of therapeutic apheresis in pediatric disorders
by: Rekha Hans, et al.
Published: (2016)

Safety of Therapeutic Apheresis in Children and Adolescents
by: Christina Taylan, et al.
Published: (2022)

Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry
by: J. Torzewski, et al.
Published: (2023)

COMBINING GENERATIONAL GENETIC AND LP(A) CASCADE TESTING TO PREDICT LP(A) AND ASSOCIATED CARDIOVASCULAR DISEASE (CVD) RISK IN YOUNG ADULTS
by: Jamal A Anthony, et al.
Published: (2023)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021)

Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis
by: Asami Fujii, et al.
Published: (2017)

Le-Lp Overlap Syndrome
by: Chatterjee Saumen, et al.
Published: (2004)

SCLE-LP overlap syndrome
by: C Shanmuga Sekar, et al.
Published: (2011)

Elevated Circulating Interleukin-27 in Patients with Coronary Artery Disease Is Associated with Dendritic Cells, Oxidized Low-Density Lipoprotein, and Severity of Coronary Artery Stenosis
by: Wen Jin, et al.
Published: (2012)

Coronary Artery Aneurysmal Disease and Acute Coronary Syndrome
by: Wesam Ostwani MD, et al.
Published: (2016)

Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review
by: Nikolaos Velidakis, et al.
Published: (2024)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
by: Akl C. Fahed, et al.
Published: (2012)

Resistin concentrations in perivascular adipose tissue as a highly sensitive marker of smoking status in patients with advanced coronary artery disease requiring coronary artery bypass grafting
by: Maciej Rachwalik, et al.
Published: (2024)

Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center With the Alyx Apheresis Collection Device
by: Tovah Klein BA, et al.
Published: (2021)

Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease
by: Lauren L. Ching, et al.
Published: (2020)

The Relationship Between the Level of Serum ESM‐1 and Lp‐PLA2 in Patients With Acute ST‐Segment Elevation Myocardial Infarction
by: Peng Wei, et al.
Published: (2021)

Current Management and Future Perspectives in the Treatment of Lp(a) with a Focus on the Prevention of Cardiovascular Diseases
by: Juan M. Farina, et al.
Published: (2023)

Prevalence and pattern of lipid disorders in Saudi patients with angiographically documented coronary artery disease
by: Abdullah M Al-Shehri
Published: (2014)

PCSK9 - new perspectives for lipid-lowering pharmacotherapy in patients with coronary artery disease
by: Natalia Pauli, et al.
Published: (2020)

Apheresis Procedure could Prevent Sequele of Hsv1 Encephalitis-Case Report
by: Vjeroslava Slavic
Published: (2020)

The impact of lipid-lowering medications on coronary artery plaque characteristics
by: Vishnu Priya Pulipati, et al.
Published: (2021)

Evaluación de un método rápido para la detección de niveles elevados de lipoproteína (a): AubioDOT Lp (a). Evaluation of a fast method for the detection of elevated levels of lipoprotein (a): AuBioDOT Lp(a).
by: Maritza B. Torres, et al.
Published: (1998)

Perceived stress level is associated with coronary artery disease severity in patients with ST-segment elevation myocardial infarction
by: Serkan Kahraman, et al.
Published: (2020)

Lp-PLA2 Inhibition-The Atherosclerosis Panacea?
by: Mahir Karakas, et al.
Published: (2010)

Progression prediction of coronary artery lesions by echocardiography-based ultrasomics analysis in Kawasaki disease
by: Dan Xu, et al.
Published: (2024)

Lipid Variables Related to the Extent and Severity of Coronary Artery Disease in Non-Diabetic Turkish Cypriots
by: Cenk CONKBAYIR, et al.
Published: (2015)

Lp(a) and inflammation: a new insight into atherosclerosis
by: Hangyu Pan, et al.
Published: (2023)

Xanthomas heralding pediatric coronary artery disease
by: Alexandra Edelman, MD, et al.
Published: (2020)

Coronary Artery Diseases
Published: (2012)

Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study
by: Yuhan Xia, et al.
Published: (2022)

The effect of resistance exercise on lipid profile of coronary artery disease patients: A randomized clinical trial
by: Zahra Salehi, et al.
Published: (2017)

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
by: Ana Victoria Carro Martínez, et al.
Published: (2021)

Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency*
by: Ying Cheng, et al.
Published: (2024)

The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
by: Jinyan Chen, et al.
Published: (2021)

Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain
by: Javier Martin de Carpi
Published: (2022)